Author Index

Search or browse for an author across our entire electronic archive

Search results for: Y
Results 51 - 60 of 434 shown below

  • Yamamoto, J

    H Ueno, T Kosuge, Y Matsuyama, J Yamamoto, A Nakao, S Egawa, R Doi, M Monden, T Hatori, M Tanaka, M Shimada and K Kanemitsu

    A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

    advance online publication, 2009-08-18 00:00:00.000;

    doi:10.1038/sj.bjc.6605256

  • Yamamoto, K

    H Katori, M Tsukuda, I Mochimatu, J Ishitoya, S Kawai, Y Mikami, H Matsuda, Y Tanigaki, C Horiuchi, Y Ikeda, T Taguchi, M Ono, T Yoshida, S Hirose, Y Sakuma and K Yamamoto

    Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

    doi:10.1038/sj.bjc.6601471

  • T Iehara, H Hosoi, K Akazawa, Y Matsumoto, K Yamamoto, S Suita, T Tajiri, T Kusafuka, E Hiyama, M Kaneko, F Sasaki, T Sugimoto and T Sawada

    MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

    advance online publication, 2006-05-02 00:00:00.000;

    doi:10.1038/sj.bjc.6603149

  • K Nouso, Y M Ito, K Kuwaki, Y Kobayashi, S Nakamura, Y Ohashi and K Yamamoto

    Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis

    advance online publication, 2008-03-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604282

  • N Iizuka, K Hirose, T Noma, S Hazama, A Tangoku, H Hayashi, T Abe, K Yamamoto and M Oka

    The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma

    doi:10.1038/sj.bjc.6690717

  • T Kato, T Kimura, R Miyakawa, A Fujii, K Yamamoto, S Kameoka, T Nishikawa and T Kasajima

    Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer

    doi:10.1054/bjoc.1999.0934

  • H Tsuda, K Yamamoto, T Inoue, I Uchiyama and N Umesaki

    The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma

    doi:10.1054/bjoc.1999.0980

  • N Toshikuni, K Nouso, T Higashi, H Nakatsukasa, T Onishi, T Kaneyoshi, Y Kobayashi, K Kariyama, K Yamamoto and T Tsuji

    Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma

    doi:10.1054/bjoc.1999.1008

  • N Mori, M Oka, S Hazama, N Iizuka, K Yamamoto, S Yoshino, A Tangoku, T Noma and K Hirose

    Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads

    doi:10.1054/bjoc.2000.1408

  • Yamamoto, M

    R Suzuki, Y Hasegawa, K Baba, H Saka, H Saito, H Taniguchi, M Yamamoto, S Matsumoto, K Kato, T Oishi, K Imaizumi and K Shimokata

    A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

    advance online publication, 2006-05-02 00:00:00.000;

    doi:10.1038/sj.bjc.6603159

  • K Fujita, K Denda, M Yamamoto, T Matsumoto, M Fujime and T Irimura

    Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients

    doi:10.1038/sj.bjc.6690355

  • Yamamoto, N

    M Yamada, S Kudoh, H Fukuda, K Nakagawa, N Yamamoto, Y Nishimura, S Negoro, K Takeda, M Tanaka and M Fukuoka

    Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

    doi:10.1038/sj.bjc.6600464

  • N Yamamoto, M Fukuoka, S-I Negoro, K Nakagawa, H Saito, K Matsui, M Kawahara, H Senba, Y Takada, S Kudoh, T Nakano, N Katakami, T Sugiura, T Hoso and Y Ariyoshi

    Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

    doi:10.1038/sj.bjc.6601462

  • K Nakagawa, S Kudoh, K Matsui, S Negoro, N Yamamoto, J E Latz, S Adachi and M Fukuoka

    A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours

    advance online publication, 2006-08-29 00:00:00.000;

    doi:10.1038/sj.bjc.6603321

  • I Sekine, N Yamamoto, K Nishio and N Saijo

    Emerging ethnic differences in lung cancer therapy

    advance online publication, 2008-11-04 00:00:00.000;

    doi:10.1038/sj.bjc.6604721

  • C Tanai, H Nokihara, S Yamamoto, H Kunitoh, N Yamamoto, I Sekine, Y Ohe and T Tamura

    Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604982

  • F Ohyanagi, N Yamamoto, A Horiike, H Harada, T Kozuka, H Murakami, K Gomi, T Takahashi, M Morota, T Nishimura, M Endo, Y Nakamura, A Tsuya, T Horai and M Nishio

    Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer

    doi:10.1038/sj.bjc.6605152

  • N Yamamoto, K Uzawa, T Yakushiji, T Shibahara, H Noma and H Tanzawa

    Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus

    doi:10.1054/bjoc.2000.1656

  • Yamamoto, S

    Y Tsubono, T Otani, M Kobayashi, S Yamamoto, T Sobue and S Tsugane

    No association between fruit or vegetable consumption and the risk of colorectal cancer in Japan

    advance online publication, 2005-04-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602566

  • C Tanai, H Nokihara, S Yamamoto, H Kunitoh, N Yamamoto, I Sekine, Y Ohe and T Tamura

    Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604982

  • J Kurebayashi, S Yamamoto, T Otsuki and H Sonoo

    Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect

    doi:10.1038/sj.bjc.6690099

  • J Kurebayashi, T Otsuki, M Kurosumi, S Yamamoto, K Tanaka, M Mochizuki and H Nakamura

    Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6

    doi:10.1038/sj.bjc.6690114

  • H Kunisue, J Kurebayashi, T Otsuki, C K Tang, M Kurosumi, S Yamamoto, K Tanaka, H Doihara, N Shimizu and H Sonoo

    Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2

    doi:10.1054/bjoc.1999.0875

  • T Kawaguchi, S Yamamoto, N Naka, K Okishio, S Atagi, M Ogawara, S Hosoe, M Kawahara and K Furuse

    Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy

    doi:10.1054/bjoc.1999.0936

  • Yamamoto, T

    K Kaneko, H Ito, K Konishi, T Kurahashi, T Ito, A Katagiri, T Yamamoto, T Kitahara, Y Mizutani, A Ohtsu and K Mitamura

    Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus

    doi:10.1038/sj.bjc.6600684

  • T Uenishi, S Kubo, K Hirohashi, H Tanaka, T Shuto, T Yamamoto and S Nishiguchi

    Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

    doi:10.1038/sj.bjc.6601026

  • T Yamamoto, K Konishi, T Yamochi, R Makino, K Kaneko, T Shimamura, H Ota and K Mitamura

    No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas

    doi:10.1038/sj.bjc.6601070

  • H Ota, H Nagano, M Sakon, H Eguchi, M Kondo, T Yamamoto, M Nakamura, B Damdinsuren, H Wada, S Marubashi, A Miyamoto, K Dono, K Umeshita, S Nakamori, K Wakasa and M Monden

    Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

    advance online publication, 2005-08-16 00:00:00.000;

    doi:10.1038/sj.bjc.6602742

  • K Konishi, M Takimoto, K Kaneko, R Makino, Y Hirayama, H Nozawa, T Kurahashi, Y Kumekawa, T Yamamoto, H Ito, N Yoshikawa, M Kusano, K Nakayama, B J Rembacken, H Ota and M Imawari

    BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias

    advance online publication, 2005-12-13 00:00:00.000;

    doi:10.1038/sj.bjc.6602911

  • K Kaneko, A Katagiri, K Konishi, T Kurahashi, H Ito, Y Kumekawa, T Yamamoto, T Muramoto, Y Kubota, H Nozawa, R Makino, M Kushima and M Imawari

    Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus

    doi:10.1038/sj.bjc.6603582

  • Yamamoto, Y

    T Kubota, H Fujiwara, Y Ueda, T Itoh, T Yamashita, T Yoshimura, K Okugawa, Y Yamamoto, Y Yano and H Yamagishi

    Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients

    doi:10.1038/sj.bjc.6600233

  • M Shimamura, H Nagasawa, H Ashino, Y Yamamoto, T Hazato, Y Uto, H Hori and S Inayama

    A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors

    doi:10.1038/sj.bjc.6600667

  • S Okubo, J Kurebayashi, T Otsuki, Y Yamamoto, K Tanaka and H Sonoo

    Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells

    doi:10.1038/sj.bjc.6601504

  • K Ota, H Fujimori, M Ueda, S Shiniriki, M Kudo, H Jono, Y Fukuyoshi, Y Yamamoto, H Sugiuchi, H Iwase, M Shinohara and Y Ando

    Midkine as a prognostic biomarker in oral squamous cell carcinoma

    advance online publication, 2008-08-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604539

  • Yamamoto-Yamaguchi, Y

    Y Honma, Y Yamamoto-Yamaguchi and Y Kanatani

    Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice

    doi:10.1038/sj.bjc.6690327

  • Yamamura, Y

    S Ito, H Nakanishi, Y Kodera, Y Mochizuki, M Tatematsu and Y Yamamura

    Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients

    advance online publication, 2005-10-04 00:00:00.000;

    doi:10.1038/sj.bjc.6602802

  • N Futamura, S Nakamura, M Tatematsu, Y Yamamura, R Kannagi and H Hirose

    Clinicopathologic significance of sialyl Le xexpression in advanced gastric carcinoma

    doi:10.1054/bjoc.2000.1484

  • Yamana, H

    Y Maeda, N Hida, F Niiya, K Katagiri, M Harada, H Yamana, T Kamura, M Takahashi, Y Sato, S Todo and K Itoh

    Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients

    doi:10.1038/sj.bjc.6600548